Michael B. Kastan is the executive director of the Duke Cancer Institute and professor of pharmacology and cancer biology.
Career[edit]
Kastan received his bachelor's degree in chemistry from the University of North Carolina at Chapel Hill and his MD and PhD from Washington University School of Medicine in 1984.[1] He did a residency in pediatrics at Johns Hopkins Hospital.[2]
In 2004, he became director of the Comprehensive Cancer Center at St. Jude Children's Research Hospital,[3] where he worked until moving to Duke to lead the Duke Cancer Institute in 2011. He was the editor-in-chief of Molecular Cancer Research from 2002 to 2012.[4]
Kastan's research is focused on cell signaling and DNA damage and repair mechanisms in cancer.[4]
Awards[edit]
- 1995 Elected to the American Society for Clinical Investigation[5]
- 1999 Stohlman Award, Leukemia Society of America[4]
- 2003 Elected member, Association of American Physicians
- 2014 Elected fellow, American Academy of Arts and Sciences
- 2014 Elected fellow, American Association for the Advancement of Science
- 2016 Elected to the National Academy of Sciences[2]
- 2017 Elected fellow of the AACR Academy
References[edit]
- ^ "Michael B. Kastan, MD, PhD".
- ^ a b "Duke Cancer Leader Michael Kastan Named to National Academy of Sciences - Duke School of Medicine". medschool.duke.edu.
- ^ "Pioneering cancer researcher will lead the new Duke Cancer Institute - DCRI". DCRI. 16 May 2011.
- ^ a b c "Michael B. Kastan, MD, PhD".
- ^ "Michael B. Kastan, MD, PhD".
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
